BBHC
AGN

Brown Brothers Harriman & Co’s Allergan Inc AGN Stock Holding History

Brown Brothers Harriman & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-18,967
Closed -$4.03M – 924
2014
Q4 		$4.03M Sell
18,967
-1,005
-5% -$200K 0.02% 113
2014
Q3 		$3.56M Sell
19,972
-7,875
-28% -$1.31M 0.01% 121
2014
Q2 		$4.71M Buy
27,847
+7,894
+40% +$1.23M 0.02% 115
2014
Q1 		$2.48M Buy
19,953
+803
+4% +$97.8K 0.01% 134
2013
Q4 		$2.13M Sell
19,150
-752
-4% -$71.8K 0.01% 140
2013
Q3 		$1.8M Sell
19,902
-31,657
-61% -$2.84M 0.01% 144
2013
Q2 		$4.34M Buy
+51,559
New +$5.35M 0.02% 117

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Brown Brothers Harriman & Co's AGN Position: Q1 2015 in Review

Brown Brothers Harriman & Co sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 18,967 shares — an estimated $4.03M sold.

Brown Brothers Harriman & Co first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $4.71M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Brown Brothers Harriman & Co reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 18,967 Allergan Inc shares in Q1 2015, an estimated $4.03M.
  • Brown Brothers Harriman & Co first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Brown Brothers Harriman & Co's Allergan Inc position peaked at $4.71M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2015, filed 15 May 2015.